1. Volume 11, Issue 1, Pages 158-162 (January 2014)
Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis 
Brandon C. Varr, MD, Shirin Zarafshar, MD, Terra Coakley, MAT, Michaela Liedtke, MD, Richard A. Lafayette, MD, Sally Arai, MD, Stanley L. Schrier, MD, Ronald M. Witteles, MD 
Heart Rhythm 
Volume 11, Issue 1, Pages (January 2014)
DOI: /j.hrthm
Copyright © 2014 Heart Rhythm Society Terms and Conditions

2. Figure 1
Comparison of NT-proBNP levels in patients with and without NSVT (P = .24). NSVT = nonsustained ventricular tachycardia; NT-proBNP = N-terminal pro–brain natriuretic peptide.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2014 Heart Rhythm Society Terms and Conditions

3. Figure 2
Intracardiac electrogram from patient with cardiac amyloidosis and ventricular tachycardia showing successful ICD defibrillation. ICD = implantable cardioverter-defibrillator; NSVT = nonsustained ventricular tachycardia; NYHA = New York Heart Association; VT = ventricular tachycardia.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2014 Heart Rhythm Society Terms and Conditions

4. Figure 3
Stanford Amyloid Center’s ICD implantation criteria for cardiac amyloidosis. ICD = implantable cardioverter-defibrillator.
Heart Rhythm  , DOI: ( /j.hrthm )
Copyright © 2014 Heart Rhythm Society Terms and Conditions